Safety of COVID-19 vaccines regarding cardiovascular events: a systematic review and meta-analysis

1 September 2024 (09:40 - 09:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Isa Khaheshi

Modarres Hospital, Tehran (Iran (Islamic Republic of))

4 More presentations in this session

Presentation thumbnail

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: a participant level pooled analysis of CREDENCE and CANVAS

Doctor S. Chatur (Boston, US)

Abstract Slides Video

Presentation thumbnail

International cooperation in cardiogenic shock is key to improving outcomes: Cardiogenic Shock Working Group impacts a single-center in a developing country.

Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)

Abstract Slides Video

Presentation thumbnail

The impact of the 2022 definition of pulmonary hypertension on long-term clinical outcomes in patients with heart failure with preserved ejection fraction

Doctor F. Sera (Suita, JP)

Abstract Slides Video

Presentation thumbnail

Remote management of worsening heart failure events and subsequent rate of emergency department admission

Mr J. Florence (Paris, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Modern views on worsening heart failure

The Event

Event poster

ESC Congress 2024

1 September 2024 09:40 CET

You may be interested in

Congress Presentation

Long term cardiac function and symptoms in patients following COVID-19 vaccination myocarditis

Congress Presentation

COVID-19 vaccines and cardiovascular risks: a registry-based study using a self-controlled risk interval design

Congress Presentation

Vaccination as a new form of cardiovascular prevention: an ESC Clinical Consensus Statement

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources